Ceribell CBLL
NASDAQ CBLL
$24.41 +0.10 (+0.41%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ceribell (CBLL) Liabilities and Shareholders Equity (2023 - 2026)

Ceribell's (CBLL) quarterly Liabilities and Shareholders Equity came in at $166.3 million in Q2 2026, down 19.91% on a YoY basis from $207.7 million in Q2 2025, and down 6.59% quarter-over-quarter from $178.1 million in Q1 2026.

Analysis

Ceribell (CBLL) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends

Ceribell (CBLL) has reported Liabilities and Shareholders Equity for 4 consecutive years, with $166.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Liabilities and Shareholders Equity fell 19.91% year-over-year to $166.3 million; the trailing twelve-month figure through Jun 2026 stood at $739.8 million (up 6.65% YoY), and the FY2025 full-year result was $195.8 million, down 13.14% from the prior year.
  • Liabilities and Shareholders Equity declined to $166.3 million in Q2 2026 per CBLL's latest filing, from $178.1 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $225.4 million in Q4 2024 and bottomed at $47.1 million in Q3 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $165.8 million across 4 years, with a median of $195.8 million in 2025.
  • The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity jumped 323.99% in 2025, then fell 19.91% in 2026.
  • Over 4 years, Liabilities and Shareholders Equity stood at $58.9 million in 2023, then surged by 282.56% to $225.4 million in 2024, then dropped by 13.14% to $195.8 million in 2025, then fell by 15.04% to $166.3 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $166.3 million, $178.1 million, and $195.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 GE HealthCare Technologies 31.10 Bn 29.22 Bn 2.18 Bn 37.25 Bn
2 Lantheus Holdings 6.59 Bn 6.00 Bn 241.86 Mn 2.41 Bn
3 Heartflow 4.24 Bn 3.87 Bn 53.19 Mn 344.46 Mn
4 Neogen 2.58 Bn 2.39 Bn 107.80 Mn 3.35 Bn
5 Butterfly Network 1.75 Bn 1.62 Bn 23.29 Mn 283.00 Mn
6 QuidelOrtho 954.15 Mn 830.75 Mn - 5.72 Bn
7 Ceribell 944.88 Mn 815.62 Mn 25.94 Mn 166.35 Mn
8 Anbio Biotechnology 941.05 Mn 929.15 Mn - 30.24 Mn
9 Varex Imaging 780.16 Mn 694.86 Mn 76.70 Mn 1.10 Bn
10 Prenetics Global 357.49 Mn 298.35 Mn 30.20 Mn 153.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 166.35 Mn
Mar 31, 2026 178.08 Mn
Dec 31, 2025 195.80 Mn
Sep 30, 2025 199.53 Mn
Jun 30, 2025 207.69 Mn
Mar 31, 2025 213.47 Mn
Dec 31, 2024 225.41 Mn
Sep 30, 2024 47.06 Mn
Dec 31, 2023 58.92 Mn